INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 9 filers reported holding INNATE PHARMA S A in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1 | 0.0% | 412 | 0.0% | 0.00% | – |
Q1 2024 | $1 | 0.0% | 412 | 0.0% | 0.00% | – |
Q4 2023 | $1 | 0.0% | 412 | 0.0% | 0.00% | – |
Q3 2023 | $1 | 0.0% | 412 | 0.0% | 0.00% | – |
Q2 2023 | $1 | 0.0% | 412 | 0.0% | 0.00% | – |
Q1 2023 | $1 | -50.0% | 412 | 0.0% | 0.00% | – |
Q4 2022 | $2 | – | 412 | +235.0% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 123 | -94.4% | 0.00% | – |
Q2 2022 | $6,000 | -45.5% | 2,179 | -36.1% | 0.00% | – |
Q1 2022 | $11,000 | – | 3,411 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 146 | $545 | 0.00% |
CITIGROUP INC | 54 | $201 | 0.00% |
Optiver Holding B.V. | 105,534 | $394,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 71,684 | $267 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,315 | $49,665 | 0.00% |
Tower Research Capital LLC (TRC) | 2,954 | $11 | 0.00% |
MORGAN STANLEY | 49,367 | $184,138 | 0.00% |
ROYAL BANK OF CANADA | 125 | $0 | 0.00% |
Steward Partners Investment Advisory, LLC | 500 | $1,865 | 0.00% |